The Technical AnalystExchange: NASDAQ Sector: Healthcare Industry: Biotechnology
XOMA Corporation Price, Forecast, Insider, Ratings, Fundamentals & Signals
1.09% $25.09
America/New_York / 19 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 285.50 mill |
| EPS: | 1.001 |
| P/E: | 25.06 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 11.38 mill |
| Avg Daily Volume: | 0.0014 mill |
| RATING 2024-04-19 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Sell | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Sell | |
| DE: | Strong Buy | |
| P/E: | Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 25.06 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 4.26x |
| Company: PE 25.06 | industry: PE 5.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$-4.19 (-116.71%) $-29.28 |
| Date: 2024-04-19 |
| Expected Trading Range (DAY) |
|---|
|
$ 24.84 - 25.34 ( +/- 1.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-08 | Hughes Owen | Buy | 275 000 | Performance Stock Units |
| 2023-10-03 | Sitko Bradley | Buy | 250 | Common Stock |
| 2023-10-02 | Sitko Bradley | Buy | 1 500 | Common Stock |
| 2023-10-02 | Hughes Owen | Buy | 1 000 | Common Stock |
| 2023-09-26 | Hughes Owen | Buy | 2 499 | Common Stock |
| INSIDER POWER |
|---|
| 100.00 |
| Last 90 transactions |
| Buy: 3 445 824 | Sell: 117 506 |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $25.09 (1.09% ) |
| Volume | 0.0010 mill |
| Avg. Vol. | 0.0014 mill |
| % of Avg. Vol | 73.26 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For XOMAP
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
XOMAP
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.